ULTRASONIC AND MULTI-ENERGY SURGICAL INSTRUMENTS, SYSTEMS, AND METHODS FOR SEALING, CUTTING, AND / OR SENSING TISSUE - Patent application
The ultrasonic surgical instrument addresses the challenge of precise tissue sealing and cutting by employing a blade and jaw design with differential clamping forces and multi-energy delivery, achieving efficient and precise tissue treatment.
Patent Information
- Application Number
- JP2021557353
- Authority / Receiving Office
- JP · JP
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2019-03-26
- Filing Date
- 2020-03-25
- Publication Date
- 2024-12-09
- Estimated Expiration
- 2040-03-25
AI Technical Summary
Existing ultrasonic surgical instruments face challenges in efficiently sealing and cutting tissue with precise control over clamping forces and energy delivery, particularly in ensuring uniform heating and sealing of tissue edges.
The ultrasonic surgical instrument features a blade and jaw design with laterally spaced panels that apply differential clamping forces to central and lateral tissue portions, combined with energy delivery mechanisms that include ultrasonic, RF, and optical energy for precise tissue treatment and sensing.
This design allows for efficient sealing and cutting of tissue with controlled heating and sealing, providing enhanced precision and versatility in surgical procedures.
Smart Images

Figure 0007596292000001 
Figure 0007596292000002 
Figure 0007596292000003
Abstract
Description
[Technical field]
[0001] CROSS-REFERENCE TO RELATED APPLICATIONS This application claims the benefit of and priority to U.S. Provisional Patent Application Nos. 62 / 823,769 and 62 / 823,875, both filed on March 26, 2019, the entire contents of each of which are incorporated herein by reference.
[0002] The present disclosure relates to surgical instruments, systems, and methods. More particularly, the present disclosure relates to ultrasonic and multi-energy surgical instruments, systems, and methods for sealing, cutting, and / or sensing tissue. [Background technology]
[0003] Ultrasonic surgical instruments and systems utilize ultrasonic energy, i.e., ultrasonic vibrations, to treat tissue. More specifically, ultrasonic surgical instruments and systems utilize mechanical vibrational energy transmitted at ultrasonic frequencies to coagulate, cauterize, weld, seal, cut, and / or desiccate tissue to effect hemostasis.
[0004] Ultrasonic surgical instruments typically utilize a transducer coupled to the handle of the ultrasonic surgical instrument and configured to generate ultrasonic energy for transmission along a waveguide to an end effector of the ultrasonic surgical instrument designed to treat tissue with ultrasonic energy. The transducer may be driven by an ultrasonic generator that is mounted, for example, on or within the handle of the ultrasonic surgical instrument or is located remotely, for example, as a set-top box connected to the ultrasonic surgical instrument via a surgical cable. The end effector of the ultrasonic surgical instrument may include a blade that receives ultrasonic energy from the waveguide for application to tissue and jaw members configured to clamp tissue between the blade and the jaw members to facilitate treatment thereof. Summary of the Invention [Means for solving the problem]
[0005] As used herein, the term "distal" refers to a portion that is described as being further from the user, while the term "proximal" refers to a portion that is described as being closer to the user. Further, to the extent not inconsistent, any or all of the aspects described herein may be used in conjunction with any or all of the other aspects described herein.
[0006] According to an aspect of the present disclosure, provided is an ultrasonic surgical instrument including a housing, an ultrasonic transducer supported by the housing, and an elongated assembly extending distally from the housing. The elongated assembly includes a waveguide configured to operably couple to the ultrasonic transducer. The waveguide defines a blade at its distal end. The elongated assembly further includes first and second panels spaced laterally opposite the blade and extending along at least a portion of the length of the blade, and a jaw pivotable relative to the blade and the first and second panels between a spaced position and an approximate position. In the approximate position, the blade and jaws define a first distance therebetween and are configured to grasp a central portion of tissue therebetween under a first clamping force, and the jaws and each of the first and second panels define a second distance therebetween that is greater than the first distance and is configured to grasp an outer lateral portion of tissue therebetween under a second clamping pressure that is less than the first clamping pressure. In other embodiments, the second distance can be substantially equal to or less than the first distance, such that the second clamping pressure is substantially greater than or equal to the first clamping pressure.
[0007] In one aspect of the present disclosure, the blade includes a tissue contacting surface having a convex configuration defining an apex, In such an aspect, in the clamping position, the tissue contacting surface and jaws of the blade are configured to grasp a central portion of tissue therebetween.
[0008] In another aspect of the present disclosure, the apex of the tissue contacting surface of the blade extends further towards the jaws as compared to the tissue contacting surfaces of the first and second panels.
[0009] In yet another aspect of the present disclosure, the jaw includes a structure and a jaw liner. The jaw liner defines a tissue contacting surface, and the structure defines first and second tissue contacting surfaces disposed on either side of the tissue contacting surface of the jaw liner. In such an aspect, in the approximate position, the tissue contacting surfaces of the jaw liner and the blade are configured to grasp a central portion of tissue therebetween, and the first and second tissue contacting surfaces of the structure and the first and second panels, respectively, are configured to grasp outer lateral portions of tissue therebetween.
[0010] In yet another aspect of the present disclosure, the first and second tissue contacting surfaces of the structure are recessed relative to the tissue contacting surface of the jaw liner, hi other aspects, the first and second tissue contacting surfaces of the structure are substantially horizontal, e.g., coplanar, relative to the tissue contacting surface of the jaw liner or protrude further toward the blade compared to the tissue contacting surface of the jaw liner.
[0011] In yet another aspect of the present disclosure, the blade includes a tissue contacting surface having a convex configuration defining an apex, and the jaw includes a structure and a jaw liner. The jaw liner defines a tissue contacting surface, and the structure defines first and second tissue contacting surfaces disposed on either side of the tissue contacting surface of the jaw liner. In such an aspect, in the approximate position, the tissue contacting surface of the blade and the tissue contacting surface of the jaw liner are configured to grasp a central portion of tissue therebetween, and the first and second tissue contacting surfaces of the structure and the first and second panels, respectively, are configured to grasp an outer lateral portion of tissue therebetween.
[0012] In another embodiment of the present disclosure, the first and second panels are fixed relative to the blade. Alternatively, the first and second panels are movable relative to the blade between a more proximal position and a more distal position. In such movable embodiments, the first and second panels may be movable relative to the blade between a more proximal position and a more distal position in conjunction with pivoting of the jaws between the spaced and approximated positions.
[0013] In yet another aspect of the present disclosure, the blade is curved and the first and second panels are similarly curved.
[0014] In yet another aspect of the present disclosure, the housing further supports an ultrasonic generator configured to drive the ultrasonic transducer, hi such an aspect, the housing may further support a battery assembly configured to power the ultrasonic generator.
[0015] A method of sealing and cutting tissue provided according to an embodiment of the present disclosure includes clamping tissue with an end effector including an ultrasonic blade and first and second panels disposed on opposite sides of the ultrasonic blade in a laterally spaced relationship thereto, extending along at least a portion of the length of the ultrasonic blade and the jaws. The tissue is clamped such that the ultrasonic blade and the jaws define a first distance therebetween and grasp a central portion of the tissue therebetween under a first clamping force, and such that the jaws and each of the first and second panels define a second distance therebetween that is greater than the first distance and grasp an outer lateral portion of the tissue therebetween under a second clamping pressure that is less than the first clamping pressure. In other embodiments, the second distance can be substantially equal to or less than the first distance, such that the second clamping pressure is substantially equal to or greater than the first clamping pressure.
[0016] The method further includes activating the ultrasonic blade to heat a central portion of the tissue to a first temperature, cut the central portion of the tissue, heat outer lateral portions of the tissue to a second temperature lower than the first temperature, and seal the outer lateral portions of the tissue.
[0017] In an aspect of the present disclosure, clamping the tissue includes applying a first compression to a central portion of the tissue and applying a second compression, less than the first compression, to an outer lateral portion of the tissue.
[0018] In another aspect of the present disclosure, clamping the tissue includes moving the jaws from a spaced apart position to an approximated position relative to the ultrasonic blade and the first and second panels. Moving the jaws from the spaced apart position to the approximated position can, in aspects, affect deployment of the first and second panels from a more proximal position to a more distal position.
[0019] In yet another aspect of the present disclosure, a central portion of the tissue is clamped between the ultrasonic blade and the jaw liner of the jaws, and outer lateral portions of the tissue are clamped between the jaw structures and the first and second panels.
[0020] In yet another aspect of the disclosure, activating the ultrasonic blade includes driving an ultrasonic transducer to transmit ultrasonic energy along a waveguide to the ultrasonic blade.
[0021] Also provided in accordance with an aspect of the present disclosure is an ultrasonic surgical system including an ultrasonic generator, a housing, an ultrasonic transducer supported by the housing, a waveguide coupled to the ultrasonic transducer, the waveguide defining a blade at a distal end portion thereof, and first and second panels disposed on opposite sides of the blade in a laterally spaced relationship to the blade. The ultrasonic generator is electrically coupled to the ultrasonic transducer for transmitting an ultrasonic drive signal to the ultrasonic transducer to transmit ultrasonic energy along the waveguide to the blade to drive the ultrasonic transducer. The ultrasonic generator is also electrically coupled to the blade and the first and second panels for transmitting an interrogation signal between the blade, the first and second panels, and tissue.
[0022] In one aspect of the present disclosure, the interrogation signal is a radio frequency (RF) signal. In such an aspect, the blades can be configured to define a first electrical potential and the first and second panels can be configured to define a second, different electrical potential for transmitting the RF signal between and through the tissue.
[0023] In another aspect of the disclosure, the ultrasound generator is configured to transmit the ultrasound drive signal and the probing signal alternately or simultaneously.
[0024] In another aspect of the disclosure, the ultrasonic drive signal includes an AC waveform. Alternatively or additionally, the probing signal includes at least one pulse.
[0025] In yet another aspect of the present disclosure, the ultrasound generator is configured to determine tissue impedance based on the interrogation signal.
[0026] In yet another aspect of the present disclosure, the ultrasonic surgical system further includes a jaw pivotable relative to the blade and first and second panels between a spaced position and an approximated position.
[0027] In yet another aspect of the present disclosure, the housing further supports an ultrasonic generator. In such an aspect, the housing may also support a battery assembly configured to power the ultrasonic generator.
[0028] A method of treating tissue provided according to an aspect of the present disclosure includes transmitting an ultrasonic drive signal from an ultrasonic generator to an ultrasonic transducer to drive the ultrasonic transducer and transmit ultrasonic energy along a waveguide to a blade, the method further including transmitting an interrogation signal from the ultrasonic generator through the tissue to the blade, to first and second panels disposed on opposite sides of the blade in laterally spaced relationship therewith, and back to the ultrasonic generator to determine at least one parameter of the tissue.
[0029] In one aspect of the present disclosure, transmitting the interrogation signal includes defining a first electrical potential at the blade and defining a second, different electrical potential at the first and second panels for transmitting the RF signal between and through the tissue.
[0030] In another aspect of the disclosure, transmitting the ultrasonic drive signal includes transmitting an AC waveform and / or transmitting the interrogation signal includes transmitting at least one pulse.
[0031] In yet another aspect of the disclosure, the method further includes ceasing transmission of the ultrasonic drive signal prior to transmitting the interrogation signal, and resuming transmission of the ultrasonic drive signal after transmitting the interrogation signal.
[0032] In yet another aspect of the present disclosure, the ultrasound generator is configured to alternately transmit an ultrasound drive signal and an interrogation signal.
[0033] In another aspect of the present disclosure, determining at least one parameter of the tissue includes determining tissue impedance.
[0034] In another aspect of the present disclosure, the method further includes providing at least one output in response to determining the at least one parameter of the tissue.
[0035] In yet another aspect of the present disclosure, the method further includes modifying the ultrasound drive signal in response to determining at least one parameter of the tissue.
[0036] A surgical end effector assembly provided in accordance with the present disclosure and configured for use with any of the instruments or systems detailed herein or other suitable instruments or systems includes an ultrasonic blade adapted to connect to an ultrasonic transducer configured to transmit ultrasonic energy to the ultrasonic blade, first and second panels disposed on opposite sides of the ultrasonic blade in laterally spaced relation thereto, and a jaw pivotable relative to the ultrasonic blade and the first and second panels between an open position and a clamped position. At least two of the ultrasonic blade, the first and second panels, or the jaws are energizable to different electrical potentials for transmitting electrical (e.g., radio frequency (RF) or direct current (DC)) signals between and through tissue for at least one of interrogating or treating tissue.
[0037] In one aspect of the present disclosure, the ultrasonic blade is configured to be energized to a first electrical potential and the first and second panels are configured to be energized to a second, different electrical potential for transmitting electrical signals between and through the tissue.
[0038] In another aspect of the disclosure, the jaws are configured to be energized to a first electrical potential and the first and second panels are configured to be energized to a second, different electrical potential for transmitting electrical signals between and through tissue.
[0039] In yet another embodiment, the jaw includes a structure defining first and second surfaces and a jaw liner disposed between the first and second surfaces, In such an embodiment, the first and second surfaces are energizable to transmit an electrical signal.
[0040] In yet another aspect of the present disclosure, the jaw includes a structure supporting the first and second conductive plates and a jaw liner disposed between the first and second conductive plates, In such an aspect, the first and second conductive plates are energizable to transmit an electrical signal.
[0041] In yet another aspect of the present disclosure, an insulating coating is disposed on at least one of an outer side of the ultrasonic blade or an inner side of the first and second panels.
[0042] In another aspect of the present disclosure, a gap distance is maintained between the outer side of the ultrasonic blade and the inner sides of the first and second panels.
[0043] In yet another aspect of the present disclosure, each of the first and second panels includes a vertical body and a shelf extending laterally from the vertical body, the shelf defining an opposing surface positioned to face the jaws in the clamping position of the jaws.
[0044] In yet another aspect of the present disclosure, each of the first and second panels tapers in height from its lower portion in a proximal-to-distal direction to gradually expose the bottom of the blade in the proximal-to-distal direction.
[0045] Another surgical end effector assembly provided according to the present disclosure and configured for use with any of the instruments or systems detailed herein or other suitable instruments or systems includes an ultrasonic blade adapted to connect to an ultrasonic transducer configured to transmit ultrasonic energy to the ultrasonic blade, first and second panels disposed opposite the ultrasonic blade in laterally spaced relation thereto, the ultrasonic blade, and a jaw pivotable relative to the first and second panels between an open position and a clamped position. The jaw includes a structure, a jaw liner supported by the structure and positioned to oppose the ultrasonic blade in the clamped position of the jaw, and first and second energy elements supported by the structure on either side of the jaw liner and positioned to oppose the first and second panels, respectively, in the clamped position of the jaw. The first and second energy elements are configured to facilitate delivery of another energy to tissue disposed between the first and second energy elements and the first and second panels, respectively. The another energy may be different from ultrasonic energy.
[0046] In embodiments of the present disclosure, the first and second energy elements are light emitters configured to emit light energy through tissue disposed between the first and second energy elements and the first and second panels, respectively. In such embodiments, the first and second panels may be configured as light absorbers or light reflectors.
[0047] In another embodiment of the present disclosure, the first and second energy elements are ultrasound transducers configured to emit ultrasound energy through tissue disposed between the first and second energy elements and the first and second panels, respectively. In such an embodiment, the first and second panels may be configured as ultrasound absorbers or ultrasound reflectors.
[0048] In yet another aspect of the present disclosure, the first and second energy elements are thermal heaters configured to conduct thermal energy to tissue disposed between the first and second energy elements and the first and second panels, respectively.
[0049] In yet another aspect of the present disclosure, another energy is utilized to treat and / or probe tissue. The present invention provides, for example, the following: (Item 1) 1. A surgical end effector assembly comprising: an ultrasonic blade adapted to connect to an ultrasonic transducer configured to transmit ultrasonic energy to the ultrasonic blade; first and second panels disposed on opposite sides of the ultrasonic blade in laterally spaced apart relationship thereto; a jaw pivotable relative to the ultrasonic blade and the first and second panels between an open position and a clamped position; A surgical end effector assembly, wherein at least two of the ultrasonic blade, the first and second panels, or the jaws are energizable to different electrical potentials for transmitting electrical signals between and through tissue for at least one of interrogating tissue or treating tissue. (Item 2) 2. The surgical end effector assembly of claim 1, wherein the ultrasonic blade is configured to be energized to a first electrical potential and the first and second panels are configured to be energized to a second, different electrical potential for transmitting the electrical signal between and through tissue. (Item 3) 2. The surgical end effector assembly of claim 1, wherein the jaws are configured to be energized to a first electrical potential and the first and second panels are configured to be energized to a second, different electrical potential for transmitting the electrical signal between and through tissue. (Item 4) 4. The surgical end effector assembly of claim 3, wherein the jaw comprises a structure defining first and second surfaces and a jaw liner disposed between the first and second surfaces, the first and second surfaces being energizable to transmit the electrical signal. (Item 5) 4. The surgical end effector assembly of claim 3, wherein the jaw includes a structure supporting first and second conductive plates and a jaw liner disposed between the first and second conductive plates, the first and second conductive plates being energizable to transmit the electrical signal. (Item 6) 2. The surgical end effector assembly of claim 1, further comprising an insulating coating disposed on at least one of an outer side of the ultrasonic blade or an inner side of the first and second panels. (Item 7) 2. The surgical end effector assembly of claim 1, wherein a gap distance is maintained between an outer side of the ultrasonic blade and inner sides of the first and second panels. (Item 8) 2. The surgical end effector assembly of claim 1, wherein each of the first and second panels includes a vertical body and a shelf extending laterally from the vertical body, the shelf defining an opposing surface positioned to face the jaw in the clamped position of the jaw. (Item 9) 2. The surgical end effector assembly of claim 1, wherein each of the first and second panels tapers in height from a lower portion thereof in a proximal-to-distal direction to gradually expose a bottom portion of the blade in the proximal-to-distal direction. (Item 10) 2. The surgical end effector assembly of claim 1, wherein the electrical signal is a radio frequency (RF) signal. (Item 11) 2. The surgical end effector assembly of claim 1, wherein the electrical signal is a direct current (DC) signal. (Item 12) 1. A surgical end effector assembly comprising: an ultrasonic blade adapted to connect to an ultrasonic transducer configured to transmit ultrasonic energy to the ultrasonic blade; first and second panels disposed on opposite sides of the ultrasonic blade in laterally spaced apart relationship thereto; a jaw pivotable relative to the ultrasonic blade and the first and second panels between an open position and a clamped position, the jaw including a structure, a jaw liner supported by the structure and positioned against the ultrasonic blade in the clamped position of the jaw, and first and second energy elements supported by the structure on either side of the jaw liner and positioned against the first and second panels, respectively, in the clamped position of the jaw; a surgical end effector assembly, wherein the first and second energy elements are configured to facilitate delivery of another energy to tissue disposed between the first and second energy elements and the first and second panels, respectively; (Item 13) Item 13. The surgical end effector assembly according to item 12, wherein the first and second energy elements are optical emitters configured to emit optical energy through tissue disposed between the first and second energy elements and the first and second panels, respectively. (Item 14) Item 14. The surgical end effector assembly of item 13, wherein the first and second panels are configured as light absorbers or light reflectors. (Item 15) Item 13. The surgical end effector assembly according to item 12, wherein the first and second energy elements are ultrasonic transducers configured to emit ultrasonic energy through tissue disposed between the first and second energy elements and the first and second panels, respectively. (Item 16) Item 16. The surgical end effector assembly of item 15, wherein the first and second panels are configured as ultrasound absorbers or ultrasound reflectors. (Item 17) Item 13. The surgical end effector assembly according to item 12, wherein the first and second energy elements are thermal heaters configured to conduct thermal energy to tissue disposed between the first and second energy elements and the first and second panels, respectively. (Item 18) Item 13. The surgical end effector assembly of item 12, wherein the other energy is utilized to treat tissue. (Item 19) Item 13. The surgical end effector assembly of item 12, wherein the other energy is utilized to probe tissue. [Brief description of the drawings]
[0050] The above, as well as other aspects and features of the present disclosure, will become more apparent in light of the following detailed description when taken in conjunction with the accompanying drawing figures, in which like reference numbers identify similar or identical elements.
[0051] [Figure 1A] FIG. 1 is a side perspective view of an ultrasonic surgical instrument provided in accordance with the present disclosure; [Figure 1B] FIG. 1 is a perspective view of an ultrasonic surgical system provided in accordance with the present disclosure including another ultrasonic surgical instrument. [Diagram 2] FIG. 1B is an enlarged, side, longitudinal, cross-sectional view of a proximal portion of the ultrasonic surgical instrument of FIG. [Diagram 3] FIG. 1B is an enlarged perspective view of a distal portion of the ultrasonic surgical instrument of FIG. 1A showing its end effector assembly. [Figure 4] FIG. 1B is an enlarged side view of a distal portion of the ultrasonic surgical instrument of FIG. [Diagram 5]FIG. 1B is a schematic diagram of an end effector assembly of the ultrasonic surgical instrument of FIG. 1A being used to seal and cut tissue. [Figure 6] FIG. 1B is a schematic diagram of the end effector assembly and generator of the ultrasonic surgical instrument of FIG. 1A being used to interrogate tissue. [Figure 7A] FIG. 2 is a graphical diagram illustrating a generator signal as a function of time, in accordance with an aspect of the present disclosure. [Figure 7B] FIG. 2 is a graphical diagram illustrating a generator signal as a function of time, in accordance with an aspect of the present disclosure. [Figure 7C] FIG. 2 is a graphical diagram illustrating a generator signal as a function of time, in accordance with an aspect of the present disclosure. [Figure 7D] FIG. 2 is a graphical diagram illustrating a generator signal as a function of time, in accordance with an aspect of the present disclosure. [Figure 8] FIG. 1 is a schematic diagram of another end effector assembly according to the present disclosure configured for applying ultrasonic and radio frequency (RF) energy. [Figure 9] FIG. 13 is a schematic diagram of yet another end effector assembly according to the present disclosure configured for applying ultrasonic and RF energy. [Figure 10] FIG. 13 is a schematic diagram of yet another end effector assembly according to the present disclosure configured for applying ultrasonic and RF energy. [Figure 11A] FIG. 13 is a schematic diagram of yet another end effector assembly according to the present disclosure configured for applying ultrasonic and RF energy. [Figure 11B] FIG. 13 is a schematic diagram of yet another end effector assembly according to the present disclosure configured for applying ultrasonic and RF energy. [Figure 12] FIG. 1 is a cross-sectional view showing a tubeset arrangement according to the present disclosure configured for use with a surgical instrument or system configured to apply ultrasonic and RF energy. [Figure 13A]FIG. 13 is a schematic diagram of another end effector assembly according to the present disclosure configured for applying ultrasonic and light energy; [Figure 13B] FIG. 13 is a schematic diagram of another end effector assembly according to the present disclosure configured for applying ultrasonic and light energy; [Figure 14] FIG. 1 is a schematic diagram of another end effector assembly according to the present disclosure configured for applying ultrasound waves and ultrasonic energy; [Figure 15] FIG. 13 is a schematic diagram of yet another end effector assembly in accordance with the present disclosure configured for applying ultrasonic and thermal energy; [Figure 16A] FIG. 1 is a side view of another end effector assembly configured for use in an ultrasonic surgical instrument or system. [Figure 16B] FIG. 16B is a front perspective view of the end effector assembly of FIG. 16A. [Figure 17A] 1A-1D are side, front perspective, and cross-sectional views of an end effector assembly configured for use in robotic surgery. [Figure 17B] 1A-1D are side, front perspective, and cross-sectional views of an end effector assembly configured for use in robotic surgery. [Figure 17C] 1A-1D are side, front perspective, and cross-sectional views of an end effector assembly configured for use in robotic surgery. [Figure 18A] 1A-1C are side, front perspective, and cross-sectional views of another end effector assembly configured for use in a robotic surgical system. [Figure 18B] 1A-1C are side, front perspective, and cross-sectional views of another end effector assembly configured for use in a robotic surgical system. [Figure 18C] 1A-1C are side, front perspective, and cross-sectional views of another end effector assembly configured for use in a robotic surgical system. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0052] 1A and 2, an ultrasonic surgical instrument 10 provided in accordance with the present disclosure includes a handle assembly 100 and an elongate assembly 200 extending distally from the handle assembly 100. The handle assembly 100 includes a housing 110 defining a body portion 112 and a fixed handle portion 114. The handle assembly 100 further includes an activation button 120 and a clamp trigger 130.
[0053] The body portion 112 of the housing 110 is configured to support an ultrasonic transducer and generator assembly ("TAG") 300, which includes a generator 310 and an ultrasonic transducer 320. The TAG 300 may be permanently engaged with or removable from the body portion 112 of the housing 110. The generator 310 includes a housing 312 configured to house the internal electronics of the generator 310 and a cradle 314 configured to rotatably support the ultrasonic transducer 320.
[0054] 1A and 2, the ultrasonic transducer 320 includes a piezoelectric stack 322, a horn 324, a casing 326, and a bolt 328 that secures the piezoelectric stack 322 between the horn 324 and a proximal nut (not shown). The ultrasonic transducer 320 further includes a rotation knob 329 (FIG. 1). The casing 326 and the rotation knob 329 engage one another and cooperate to form an enclosure that encapsulates the proximal nut, the piezoelectric stack 322, and a portion of the horn 324, with the remainder of the horn 324 extending distally from the casing 326. The rotation knob 329 is accessible from the exterior of the handle assembly 100 and is configured for manual rotation to rotate the ultrasonic transducer 320 relative to the generator 310 and the housing 110.
[0055] A set of connectors 330 and corresponding rotational contacts 334 associated with the generator 310 and ultrasonic transducer 320, respectively, allow an ultrasonic drive signal to be communicated from the generator 310 to the piezoelectric stack 322 of the ultrasonic transducer 320 to drive the ultrasonic transducer 320, regardless of the rotational orientation of the ultrasonic transducer 320 relative to the generator 310. The horn 324 is then configured to transmit ultrasonic energy generated by the piezoelectric stack 322 to the waveguide 230 of the elongated assembly 200 for transmission along the blade 282 of the end effector 280 of the elongated assembly 200, as described in more detail below.
[0056] 1A and 2, the fixed handle portion 114 of the housing 110 defines a compartment 116 configured to receive a battery assembly 400 and a door 118 configured to enclose the compartment 116. The electrical connection assembly 140 is disposed within the housing 110 of the handle assembly 100 and functions to electrically couple the activation button 120, the generator 310 of the TAG 300, and the battery assembly 400 to one another when the TAG 300 is supported on or within the body portion 112 of the housing 110 and the battery assembly 400 is disposed within the compartment 116 of the fixed handle portion 114 of the housing 110, thus enabling activation of the ultrasonic surgical instrument 10 in response to depression of the activation button 120. In embodiments, the activation button 120 may include multiple activation stages or multiple activation buttons may be provided to enable activation in either a low power mode or a high power mode. In embodiments in which the generator 310 is remote from the ultrasonic surgical instrument 10, the generator 310 may be powered by a standard wall outlet or other power source, and therefore the battery assembly 400 and configuration of the fixed handle portion 114 for receiving the battery assembly 400 do not need to be provided.
[0057] With reference to FIG. 1B, a surgical system provided in accordance with an embodiment of the present disclosure is shown generally as identified by reference number 1010, including a surgical instrument 1100 and a surgical generator 1200. The surgical system 1010 generally differs from the surgical instrument 10 (FIG. 1A) in that rather than providing an on-board generator, e.g., generator 310 of TAG 300 (FIG. 1A), and a power source, e.g., battery assembly 400 (FIG. 1A), the surgical system 1010 includes a surgical instrument 1100 and a remotely located surgical generator 1200 connected via a cable and plug assembly 1190. The surgical generator 1200 is adapted to connect to a power source (not shown), such as, for example, a standard wall outlet. Because the surgical system 1010 may otherwise be similar to the surgical instrument 10 (FIG. 1A), only the differences therebetween are described in detail below, while the similarities are described in summary or omitted entirely. Additionally, it will be understood that aspects and features of the present disclosure made with respect to surgical instrument 10 (FIG. 1A) may be applied to surgical system 1010 as well, unless expressly contradicted.
[0058] The surgical generator 1200 of the surgical system 1010 includes an ultrasonic plug port 1230, and a radio frequency (RF) plug port 1240. The surgical generator 1200 is configured to generate an ultrasonic drive signal for output to the surgical instrument 1100 through the ultrasonic plug port 1230, activate the surgical instrument 1100 in an ultrasonic mode of operation to provide RF energy for output to the surgical instrument 1100 through the RF plug port 1240, and activate the surgical instrument 1100 in an RF mode of operation, for example, to treat tissue and / or sense one or more parameters of the tissue and / or surgical instrument 1100. It is also contemplated that a common port (not shown) configured to function as both the ultrasonic plug port 1230 and the RF plug port 1240 may be utilized.
[0059] The surgical instrument 1010 includes a handle assembly 1110, an elongate assembly 1150 extending distally from the handle assembly 1110, and a cable and plug assembly 1190 operably coupled to the handle assembly 1110 and extending therefrom for connecting to a surgical generator 1200. The elongate assembly 1150 is similar to the elongate assembly 200 (FIG. 1A), described in detail below, and may exhibit any of its features. The handle assembly 1110 is similar to the handle assembly 100 (FIG. 1A), as described in detail above, except that the body portion of the handle housing 1112 is configured only to support the ultrasonic transducer 1140, rather than receiving the TAG 300 (FIG. 1A). The ultrasonic transducer 1140 may be permanently engaged with or removable from the body portion of the housing 1112. The ultrasonic transducer 1140 includes a piezoelectric stack or other suitable ultrasonic transducer component electrically coupled to the surgical generator 1200, for example, via one or more first electrical leads 1197, to enable communication of an ultrasonic drive signal to the ultrasonic transducer 1140, driving the ultrasonic transducer 1140 to generate ultrasonic vibrational energy that is transmitted along the waveguide to the blade for treating tissue.
[0060] The activation button 1120 of the handle assembly 1100 is coupled to or between the ultrasonic transducer 1140 and / or the surgical generator 1200, e.g., via one or more first electrical leads 1197, to enable activation of the ultrasonic transducer 1140 in response to depression of the activation button 1120. In embodiments, the activation button 1120 may be an on / off switch. In other embodiments, the activation button 1120 may include multiple activation stages that enable activation from an off position to different activation positions corresponding to different modes, e.g., a first activation position corresponding to a first mode and a second activation position corresponding to a second mode. In still other embodiments, separate activation buttons may be provided, e.g., a first activation button for activating the first mode and a second activation button for activating the second mode.
[0061] 1B , the cable and plug assembly 1190 of the surgical instrument 1100 includes a cable 1192, an ultrasonic plug 1194, and an RF plug 1196. The ultrasonic plug 1194 is configured for connection with an ultrasonic plug port 1230 of the surgical generator 1200, while the RF plug 1196 is configured for connection with an electrosurgical plug port 1240 of the surgical generator 1200. In embodiments in which the generator 1200 includes a common port, the plug assembly 1190 may include a common plug (not shown) configured to function as both the ultrasonic plug 1194 and the RF plug 1196. A plurality of first electrical leads 1197 electrically coupled to the ultrasonic plug 1194 extend through the cable 1192 into the handle assembly 1110 for electrical connection to the ultrasonic transducer 1140 and / or the activation button 1120 to enable selective delivery of an ultrasonic drive signal from the surgical generator 1200 to the ultrasonic transducer 1140 upon activation of the activation button 1120 in an ultrasonic mode of operation. Additionally, a plurality of second electrical leads 1199 are electrically coupled to the RF plug 1196 and extend through the cable 1192 into the handle assembly 1110. One or more second electrical leads 1199 are electrically coupled to the activation button 1120 to enable selective delivery of RF energy from the surgical generator 1200 in an RF mode of operation, as described in more detail below.
[0062] 1A, 2, 3 and 4, the elongated assembly 200 of the ultrasonic surgical instrument 10 includes an outer drive sleeve 210, an inner support sleeve 220 disposed within the outer drive sleeve 210, a waveguide 230 extending through the inner support sleeve 220, a drive assembly 250, a rotation knob 270, and an end effector 280 including a blade 282, a jaw 284, and a pair of panels 290. A proximal portion of the outer drive sleeve 210 is operably coupled to the clamp trigger 130 of the handle assembly 100 via the drive assembly 250, while a distal portion of the outer drive sleeve 210 is operably coupled to the jaw 284. Thus, the clamp trigger 130 is selectively actuable to move the outer drive sleeve 210 about the inner support sleeve 220 to pivot the jaws 284 relative to the blade 282 of the end effector 280 from a spaced position to an approximate position to clamp tissue between the jaws 284 and the blade 282. The drive assembly 250 may provide a force-limiting feature, in which the clamping pressure applied to tissue clamped between the jaws 284 and the blade 282 is limited to a particular clamping pressure or a particular clamping pressure range. The rotation knob 270 is rotatable in either direction to rotate the elongated assembly 200 in either direction relative to the handle assembly 100.
[0063] As described above, the waveguide 230 extends through the inner support sleeve 220. The waveguide 230 defines a body 232 and a blade 282 extending from a distal end of the body 232. The waveguide 230 (including the blade 282) may be formed from titanium, a titanium alloy, or other suitable material. The blade 282 functions as a blade of the end effector 280 and may be integrally formed with the waveguide 230 or may be formed separately and then attached (permanently or removably) to the waveguide 230. The waveguide 230 further includes a proximal threaded male connector 236 configured for threaded engagement within a threaded female receiver 349 of the horn 324 such that ultrasonic motion generated by the ultrasonic transducer 320 is transmitted along the waveguide 230 to the blade 282 to treat tissue clamped between the blade 282 and the jaws 284 or positioned adjacent to the blade 282.
[0064] 3 and 4, the blade 282 of the end effector 280 defines a curved configuration, although straight configurations are also contemplated. The blade 282 may be curved in any direction relative to the jaw 284, such that, for example, the distal tip of the blade 282 curves toward the jaw 284, away from the jaw 284, or laterally relative to the jaw 284 (in either direction). Additionally, the blade 282 may be formed to include multiple curves in a similar direction, multiple curves in different directions in a single plane, and / or multiple curves in different directions in different planes. The blade 282 may additionally or alternatively be formed to include tapered configurations, a variety of different cross-sectional configurations along its length, notches, indentations, edges, protrusions, straight surfaces, curved surfaces, beveled surfaces, wide edges, narrow edges, and / or other features.
[0065] In embodiments, the blade 282 defines a generally convex first tissue contacting surface 283a, e.g., the surface facing the jaw 284. Generally, the convex first tissue contacting surface 283a may be defined by a pair of surfaces 283b (flat or arcuate surfaces) that converge at an apex 283c, or may be formed by a single arcuate surface that defines the apex 283c. The blade 282 may further define a substantially flat side 283d (except for any curvature due to the curvature of the blade 282 itself) on either side of the first tissue contacting surface 283a, and a second tissue contacting surface 283e opposite and similarly configured to the first tissue contacting surface 283a, although other configurations are contemplated. The first tissue contacting surface 283a is configured to contact tissue clamped between the blade 282 and the jaw 284, e.g., to seal and cut the clamped tissue, while the second tissue contacting surface 283e may be utilized, e.g., for tissue dissection, back scoring, etc.
[0066] Jaws 284 of end effector 280 include a more rigid structure 286 and a more compliant jaw liner 288. Structure 286 is pivotally coupled to inner support sleeve 220 and includes a pair of proximal flanges 287 that are operably associated with outer drive sleeve 210, e.g., via reception in apertures defined in outer drive sleeve 210, such that sliding of outer drive sleeve 210 about inner support sleeve 220 pivots jaws 284 from a spaced position to an approximated position relative to blade 282 to clamp tissue between jaw liner 288 of jaws 284 and blade 282.
[0067] The jaw liner 288 of the jaw 284 may be fabricated from a compliant material, such as, for example, polytetrafluoroethylene (PTFE), to allow the blade 282 to vibrate while in contact with the jaw liner 288 without damaging components of the ultrasonic surgical instrument 10 (FIG. 1), such as the structure 286 of the jaw 284, and without compromising the retention of tissue clamped between the jaw 284 and the blade 282. Other suitable materials are also contemplated. The jaw liner 288 may be formed monolithically or otherwise.
[0068] 3 and 4, the jaw liner 288 protrudes from the structure 286 such that tissue contacting surfaces 299a of the structure 286 disposed on either side of the jaw liner 288 are recessed relative to the tissue contacting surface 299b of the jaw liner 288 (see also FIG. 5). Additionally, the jaw liner 288 defines a width that approximates or is greater than the width of the blade 282 to allow tissue to be clamped between the tissue contacting surface 299b of the jaw liner 288 and the blade 282 across the entire width of the blade 282.
[0069] The panels 290 extend distally from and in laterally spaced relation to the outer and inner sleeves 210, 220 on either side of the blade 282 such that a space between the panel 290 and the blade 282, e.g., between the sides 283d of the blade 282, forms an insulating air gap therebetween. The panels 290 define a relatively thin, vertically oriented, plate-like configuration such that its height dimension extends parallel to the axis of motion of the jaws 284 between the spaced and approximated positions, and its width dimension extends perpendicular to the axis of motion of the jaws 284 between the spaced and approximated positions. In this manner, the panels 290 define a relatively narrow tissue contacting surface 292. In an embodiment, the panels 290 are flared outwardly away from the blade 282 or inwardly toward the blade 282, whereby the flared portions of the panels 290 define a larger surface area of the tissue contacting surface 292. In such embodiments, the flared portion of the panel 290 may extend generally perpendicular to the vertical body portion of the panel 290 such that the tissue contacting surface 292 is generally parallel to the tissue contacting surface 299a of the structure 286. Other configurations are also contemplated.
[0070] The panel 290, in an embodiment, is positioned such that the blade 282 is laterally centered relative to the panel 290, e.g., the panel 290 is equally spaced apart from the blade 282 on either side thereof. Additionally, in an embodiment in which the blade 282 defines a laterally curved configuration, the panel 290 may similarly define a similar curvature to track the curvature of the blade 282 and maintain a substantially uniform spacing therebetween, although other configurations are also contemplated. Alternatively, the panel 290 may be positioned such that the uniform gap between the blade 282 and the corresponding panel 290 on the concave side of the blade 282 is smaller than the uniform gap between the blade 282 and the corresponding panel 290 on the convex side of the blade 282. In an embodiment, a protrusion or other feature (not shown) extends from the panel 290 to the contacting blade 282, e.g., at a node, to maintain the proper spacing between the panel 290 and the blade 282. The panel 290 may be formed from stainless steel or other suitable material.
[0071] In an embodiment, the panel 290 defines a height that is equal to or greater than the height of the side 283d of the blade 282, but less than the overall height of the blade 282, e.g., from the apex 283c of the first tissue contacting surface 283a to the apex of the second tissue contacting surface 283e. More specifically, in an embodiment, the panel 290 is positioned vertically relative to the blade 282 such that the tissue contacting surface 292 of the panel 290 is horizontally aligned with the top end of the side 283d of the blade 282. Thus, at least a portion of the first tissue contacting surface 283a of the blade 282 extends above the panel 290 toward the jaw 284. The opposing surface 294 of the panel 290 may be horizontally aligned with the lower end of the side 283d of the blade 282, may be horizontally aligned with the apex of the second tissue contacting surface 283e of the blade 282 (as illustrated (see FIG. 5)), may be positioned between the lower end of the side 283d of the blade 282 and the apex of the second tissue contacting surface 283e, or may extend beyond the apex of the second tissue contacting surface 283e.
[0072] The panels 290 are spaced apart from one another by a distance greater than the width of the tissue contacting surface 299b of the jaw liner 288 such that no portion of the tissue contacting surface 299b of the jaw liner 288 directly opposes any tissue contacting surface 292 of the panels 290 in the vicinity of the jaw 284 (see also FIG. 5). However, the panels 290 are displaced from one another by a distance less than the width of the structure 286 such that, in addition to clamping tissue between the first tissue contacting surface 283a of the blade 282 and the tissue contacting surface 299b of the jaw liner 288 in the vicinity of the jaw 284, the distance between the tissue contacting surfaces 292 and 299a is greater than the distance (or maximum distance) between the tissue contacting surface 299b of the jaw line 288 and the first tissue contacting surface 283a of the blade 282, but tissue on either side thereof is clamped between the tissue contacting surface 292 of the panel 290 and the tissue contacting surface 299a of the structure 286. Alternatively, the longer distance between tissue contacting surface 292 and tissue contacting surface 299a may be substantially equal to or less than the distance (or maximum distance) between tissue contacting surface 299b of the jaw line 288 and the first tissue contacting surface 283a of the blade 282.
[0073] 3 and 4, the panel 290 may be fixedly engaged with and extend from the inner support sleeve 220 such that the panel 290 is fixed in position relative to the blade 282 (apart from ultrasonic vibration of the blade 282 during activation) and extends along at least a portion of the length of the blade 282. In embodiments, the blade 282 extends distally beyond the distal end of the panel 290 to allow use of the exposed distal portion of the blade 282 for tissue dissection or other purposes without obstruction from the panel 290. In such embodiments, the panel 290 may function as a depth stop that prevents the blade 282 from dissecting too far through tissue, for example, beyond the distance that the blade 282 extends distally from the panel 290.
[0074] As an alternative to the panel 290 being fixed relative to the blade 282, the panel 290 may be fixedly engaged with and extending from the outer drive sleeve 210 such that the panel 290 is movable between a more proximal position, where the panel 290 does not extend to the blade 282 or does not extend along a relatively small portion of the length of the blade 282, and a more distal position, where the panel 290 extends along the entire or a relatively large portion of the length of the blade 282 in response to translation of the outer drive sleeve 210, for example, by squeezing the clamp trigger 130 toward the fixed handle portion 114 (see FIG. 1 ). Because translation of the outer drive sleeve 210 also affects the pivoting of the jaws 284 relative to the blade 282, the more proximal position may correspond to a spaced apart position of the jaws 284, while the more distal position corresponds to an approximated position of the jaws 284.
[0075] In embodiments, the panel 290 may be engaged with, for example, a third sleeve (not shown) disposed between the outer and inner sleeves 210, 220, respectively, to permit movement of the panel 290 between a more proximal position and a more distal position. This may be accomplished independently of pivoting of the jaw 284, for example, via or in coordination with a separate actuator (not shown) disposed on the handle assembly 100 (FIG. 1), where the third sleeve is coupled to the clamp trigger 130 (FIG. 1). In embodiments in which the third sleeve is coupled to the clamp trigger 130 (FIG. 1), this may be accomplished via one of the differential deployment mechanisms detailed in U.S. Patent No. 9,375,205 to Mueller, the entire contents of which are incorporated herein by reference, to permit movement of the outer drive sleeve 220 and the panel 290 different distances in response to actuation of the clamp trigger 130 (FIG. 1).
[0076] 1-4, in use, the ultrasonic instrument 10 is advanced to a surgical site and manipulated such that the end effector 280 is positioned at tissue to be treated, disposed between the jaws 284 and the blade 282 with the jaws 284 disposed in a spaced apart position (FIG. 1), e.g., the end effector 280 is rotated via rotation of the rotation knob 329 and / or the rotation knob 270. The clamp trigger 130 is then depressed from an unactuated position to an actuated position toward the fixed handle portion 114 of the housing 110, causing the outer drive sleeve 210 to translate relative to the end effector 280 about the inner support sleeve 220, thereby pivoting the jaws 284 relative to the blade 282 from the spaced apart position toward the approximated position, clamping tissue between the jaws 284 and the blade 282 (and between the panel 290 and the jaws 284). Panel 290 may facilitate clamping, holding and manipulating the tissue "T" and may inhibit slippage thereof by providing additional surface area for clamping.
[0077] 5, the tissue "T" grasped by the end effector 280 can be generally characterized as including three portions: a central portion of tissue "T1" and a pair of outer lateral portions of tissue "T2" disposed on either side of the central portion of tissue "T1". The central portion of tissue "T1" is clamped between a first tissue contacting surface 283a of the blade 282 and a tissue contacting surface 299b of the jaw liner 288 of the jaw 284, where the apex 283c facilitates the application of a relatively high compression of the central portion of tissue "T1", and the relatively close configuration of the first tissue contacting surface 283a of the blade 282 and the tissue contacting surface 299b of the jaw liner 288 provides a relatively high clamping force to the central portion of tissue "T1". On the other hand, the outer lateral portion of tissue "T2" is clamped between a tissue contacting surface 299a of the structure 286 of the jaw 284 and a tissue contacting surface 292 of the panel 290. Due to the relatively flat configuration of the tissue contacting surface 292 of the panel, and the relatively spaced configuration of tissue contacting surface 299a and tissue contacting surface 292, the compression and clamping force applied to the outer lateral portions of tissue "T2" is relatively low. Of course, because tissue "T" is a continuous mass, portions of tissue also extend between portions "T1" and "T2". As an alternative to the above, the outer lateral portions of tissue "T2" may be clamped with a relatively high clamping force as compared to the clamping force applied to the central portion of tissue "T1".
[0078] With tissue clamped in the manner detailed above, the blade 282 may be activated, for example, via pressing the activation button 120 (FIG. 1). Referring also to FIGS. 1 and 2, upon pressing the activation button 120, a DC power signal is provided from the battery assembly 400 to the generator 310, which converts the DC power signal into a high voltage AC waveform ultrasonic drive signal that is transmitted to the piezoelectric stack 324 of the ultrasonic transducer 320. Activation of the piezoelectric stack 324 in this manner generates ultrasonic energy that is transmitted along the waveguide 230 to the ultrasonic horn 326 and to the blade 282 such that the blade 282 is ultrasonically vibrated. The ultrasonic energy provided at the blade 282 is used to heat adjacent tissue "T" to seal and cut the tissue "T". More specifically, during actuation, a central portion of tissue "T1" comes into direct contact with blade 282 and, due to the relatively high compressive and clamping forces on the central portion of tissue "T1", the central portion of tissue "T1" is heated to a relatively high temperature and incised, e.g., cut, thereby separating the outer lateral portions of tissue "T2" from one another. Although some sealing of the central portion of tissue "T1" may be achieved, the majority of the tissue effect on the central portion of tissue "T1" is cutting.
[0079] Also, during activation, the ultrasonic energy provided by the blade 282 heats the outer lateral portion of the tissue "T2". However, this is indirect heating given that the outer lateral portion of the tissue "T2" is laterally displaced from the blade 282. This, coupled with the relatively low compressive and clamping forces on the outer lateral portion of the tissue "T2", results in heating the outer lateral portion of the tissue "T2" to a relatively low temperature and sealing the outer lateral portion of the tissue "T2". While some cutting of the outer lateral portion of the tissue "T2" may be achieved, the majority of the tissue effect on the outer lateral portion of the tissue "T2" is sealing. The result of the above is that the tissue "T" is sealed at two laterally spaced locations, e.g., both portions "T2", and cut between them, e.g., portion "T1". The panel 290 may also, in embodiments, help limit heat spread laterally beyond it.
[0080] 1A-3 , the blade 282, structure 286 of the jaws 284, and / or panel 290 may additionally or alternatively be utilized to interrogate the tissue "T", for example, to obtain feedback data associated therewith for use in feedback-based control of the ultrasonic instrument 10. Further, the blade 282, structure 286 of the jaws 284, and / or panel 290 may additionally or alternatively be utilized to conduct RF energy through the tissue "T" to create a bipolar RF circuit for treatment in conjunction with or separate from the application of ultrasonic energy to the tissue "T".
[0081] To enable tissue interrogation and / or tissue treatment, the blade 282 may be electrically coupled to the generator 310 via a first electrical pathway 316, which may extend between the generator 310 and the blade 282, for example, via a connector 330, a rotating contact 334, a horn 324, and a waveguide 230 (see FIG. 2), or other suitable connections and / or components. The panel 290 is electrically coupled to the generator 310 via connected or separate electrical pathways 318a, 318b. The electrical pathways 318a, 318b may include leads, contacts, and / or conductive components of the ultrasonic instrument 10 that connect the panel 290 to the generator 310. For example, the leads and / or a portion of the outer drive sleeve 210 or the inner support sleeve 220 may electrically connect between the panel 290 and associated contacts (not explicitly identified) disposed within the body portion 112 of the housing 110 of the handle assembly 100 such that the associated contacts are configured to mate with corresponding contacts (not explicitly identified) of the TAG 300 when the TAG 300 engages the body portion 112 of the housing 110 (see FIGS. 1A and 2). In a configuration in which the generator 1200 is remotely disposed and coupled to the ultrasonic surgical instrument 1010, for example via a cable and plug assembly 1190, the leads 1199 extend through the cable and plug assembly 1190 to the generator 1200 for connecting the panel 290 to the generator 1200 (see FIG. 1B). Additionally or alternatively, the structure 286 of the jaw 284 may be electrically coupled to the generator 310, for example via electrical pathway 316, with the panel 290, for example via electrical pathway 318a and / or 318b, or with the blade 282.
[0082] Continuing with reference to FIG. 6, to interrogate the tissue "T", the generator 310 is configured to transmit an interrogation signal "IS" to the blade 282 via electrical pathway 316. The interrogation signal "IS" may be, for example, a radio frequency (RF) signal at a first potential, for example a positive potential (+). The interrogation signal "IS" may include one pulse or multiple pulses. The generator 310 also establishes a second, different potential, for example a negative potential (-), at the panel 290 such that the interrogation signal "IS" is transmitted from the blade 282 through the tissue "T" to the panel 290 due to the potential difference therebetween. The signal is returned to the generator 310 via electrical pathways 318a, 318b, thus enabling the generator 310 to evaluate the returned signal. In other embodiments, rather than the panels 290 defining the same electrical potential and the blades 282 defining different electrical potentials, the panels 290 may define different electrical potentials (with the blades 282 not forming part of an interrogation circuit) to allow the interrogation signal "IS" to be transmitted from one panel 290 through the tissue to the other panel 290. Additionally, as noted above, the structure 286 of the jaws 284 may be electrically coupled to the generator 310 and may define the same electrical potential as either the panel 290 or the blades 282 to allow, for example, the interrogation signal "IS" to be transmitted between the panel 290 and both the structure 286 and the blades 282, or between the blades 282 and both the structure 286 and the panel 290. Alternatively, the structure 286 of the jaws 284 may replace the panel 290 or the blades 282 in the circuit to allow, for example, the interrogation signal "IS" to be transmitted between the panel 290 and the structure 286, or between the blades 282 and the structure 286.
[0083] The generator 310 is configured to evaluate the returned signals, e.g., their voltage, current, resistance, etc., and determine one or more parameters of the tissue "T" based thereon. For example, the generator 310 may be configured to determine an impedance of the tissue "T" that is indicative of whether the tissue "T" is adequately sealed. Thus, the interrogation signal "IS" may be utilized to determine whether the tissue "T" is adequately sealed. If the tissue "T" is determined to be adequately sealed, the generator 310 may be configured to generate an audible sound, a visual indicator, tactile feedback, and / or other output to indicate to the surgeon that the tissue "T" is adequately sealed. Additionally or alternatively, the determination of adequately sealed tissue may be utilized as part of a feedback loop, for example, to modify the ultrasonic drive signal output from the generator 310, e.g., by increasing power, to facilitate cutting of the sealed tissue. Other tissue parameters may additionally or alternatively be utilized to determine whether the tissue is sealed, and / or for other purposes. For example, temperature measurements of one or both of the panels 290 at one or more locations thereon may be made using, for example, thermocouples and fed back to the generator 310.
[0084] Continuing to refer to FIG. 6, as noted above, the blade 282, jaw 284 structure 286, and / or panel 290 may additionally or alternatively be utilized to treat tissue with additional forms of energy (other than ultrasonic energy). More specifically, the blade 282, jaw 284 structure 286, and / or panel 290 may conduct RF energy through tissue "T" to create a bipolar RF circuit for treatment in conjunction with or separate from the application of ultrasonic energy to tissue "T". That is, rather than or in addition to providing an interrogation signal "IS" through tissue "T" as detailed above, tissue treatment energy "TT" may be provided. For example, a bipolar RF tissue treatment current "TT" may be conducted through tissue (using any of the electrical configurations detailed herein). That is, to treat tissue "T", the generator 310 may be configured to energize the blade 282 with RF energy at a first potential, e.g., a positive potential (+), via electrical pathway 316, and to energize the panel 290 with RF energy at a second, different potential, e.g., a negative potential (-), via electrical pathways 318a, 318b, such that a potential gradient is established between the blade 282 and the panel 290 enabling conduction of energy, e.g., a bipolar RF tissue treatment current "TT", through the tissue disposed therebetween for treating through the tissue disposed therebetween. Additionally, as noted above, the structure 286 of the jaws 284 may be electrically coupled to the generator 310 and may define the same electrical potential as either the panel 290 or the blade 282, for example, to enable conduction of a bipolar RF tissue treatment current "TT" between the panel 290 and both the structure 286 and the blade 282 to treat tissue therebetween, or between the blade 282 and both the structure 286 and the panel 290 to treat tissue therebetween. Alternatively, the structure 286 of the jaws 284 may replace the panel 290 or the blade 282 in the circuit, for example, to enable conduction of a bipolar RF tissue treatment current "TT" between the panel 290 and the structure 286 to treat tissue therebetween, or to enable conduction between the blade 282 and the structure 286 to treat tissue therebetween.
[0085] Although exemplary interrogation signals "IS" and tissue treatment energies "TT" are detailed above utilizing RF energy, other forms of energy are also contemplated, such as, for example, microwave energy, thermal energy, light energy (such as infrared energy), ultrasound energy, low frequency or direct current electrical energy, etc. Various configurations that facilitate the application of one or more of these energies for interrogating and / or treating tissue in conjunction with ultrasound tissue treatment are detailed below with respect to Figures 8-19C.
[0086] Turning to Figures 7A-7D, various energy delivery configurations for delivering an ultrasonic drive signal to tissue to treat the tissue, an interrogation signal to tissue to sense one or more parameters, and / or energy to tissue to treat the tissue as a function of time are shown as graphical representations.
[0087] As described above, in use, and referring to FIG. 7A in conjunction with FIGS. 2, 5, and 6, the generator 310 outputs a high voltage AC waveform ultrasonic drive signal "UDS" to drive the piezoelectric stack 324 of the ultrasonic transducer 320 such that ultrasonic energy is transmitted along the waveguide 230 to the ultrasonic horn 326 and to the blade 282 to, for example, seal and / or cut tissue. The generator 310 may be further configured to stop outputting the ultrasonic drive signal "UDS", output an interrogation signal "IS" (one or more pulses thereof), and then resume outputting the ultrasonic drive signal "UDS". The ultrasonic drive signal "UDS" may be stopped and the interrogation signal "IS" may be output periodically at fixed or variable intervals. For example, fewer stop and interrogation signals "IS" may be provided when activation is initiated, and more stop and interrogation signals "IS" may be provided as activation time increases. In an embodiment, rather than ceasing the output of the ultrasonic drive signal "UDS", the interrogation signal "IS" may be output simultaneously with the ultrasonic drive signal "UDS", periodically, continuously, or in any other suitable manner.
[0088] The frequency at which the interrogation signal "IS" is output may additionally or alternatively depend on the operating mode and / or other factors. For example, the interrogation signal "IS" may be provided more frequently, e.g., at shorter intervals, in a high power operating mode and less frequently, e.g., at longer intervals, in a low power operating mode. As another example, the frequency at which the interrogation signal "IS" is output may depend on a determined tissue parameter, e.g., the interrogation signal "IS" may be output more frequently as the tissue impedance indicates that it is approaching a sufficiently sealed condition. The number of pulses of each interrogation signal "IS" may also be fixed or variable, as may the frequency of the interrogation signal "IS", or in any other suitable manner.
[0089] 7B, instead of ceasing output of the ultrasonic drive signal "UDS", outputting the interrogation signal "IS", and then resuming output of the ultrasonic drive signal "UDS", the ultrasonic drive signal "UDS" may be supplied continuously while the interrogation signal "IS" is output periodically at fixed or variable intervals such that both the ultrasonic drive signal "UDS" and the interrogation signal "IS" are supplied simultaneously while the interrogation signal "IS" is supplied. The interrogation signal "IS" may be otherwise similar, as detailed above.
[0090] 7C, for both the delivery of the ultrasonic drive signal "UDS" to drive the piezoelectric stack 324 of the ultrasonic transducer 320 such that ultrasonic energy is transmitted along the waveguide 230 to the ultrasonic horn 326 and to the blade 282 to treat tissue (see FIGS. 3 and 5), and to deliver other energy, such as conducting a bipolar RF tissue treatment current "TT" between the blade 282, the panel 290, and / or the structure 286 to treat tissue, the ultrasonic drive signal "UDS" and the tissue treatment energy "TT" may be delivered simultaneously or with at least a partially overlapping temporal relationship. The simultaneous delivery of ultrasound and RF (or other additional energy) to tissue may be utilized to seal tissue and / or achieve other tissue effects.
[0091] 7D, with respect to both the delivery of the ultrasonic drive signal "UDS" and the delivery of other energies, for example, the ultrasonic drive signal "UDS" and tissue treatment energy "TT" may be delivered simultaneously with the ultrasonic drive signal "UDS" at a first level during the tissue sealing period "SP" to conduct a bipolar RF tissue treatment current "TT" between the blade 282, the panel 290, and / or the structure 286 to treat the tissue. Once the tissue is sealed, after a predetermined time, upon receipt of a user initiated signal, or based on other signals and / or feedback, the tissue cutting period "CP" is initiated, the tissue treatment energy "TT" is stopped, and the ultrasonic drive signal "UDS" is increased from the first level to a second level, e.g., from a first amplitude to a second, greater amplitude, to increase the speed of the blade 282 (FIG. 5) to facilitate cutting of the sealed tissue.
[0092] 8 illustrates another end effector assembly 580 according to the present disclosure configured for use with any of the instruments or systems detailed herein. End effector assembly 580 is similar to end effector assembly 280 (FIGS. 3-5), except that end effector assembly 580 does not include a panel.
[0093] With respect to delivery of ultrasonic energy using the end effector assembly 580, ultrasonic energy is transmitted to the blade 582 to treat tissue clamped between the blade 582 and the jaw liner 588 of the jaw 584 or disposed near the blade 582.
[0094] To supply other energy, e.g. RF energy, to interrogate tissue, a generator (not shown) is configured to transmit an interrogation signal via a first electrical path, e.g. an RF signal at positive potential (+), to the blade 582, and establish a second different potential structure 586 of the jaw 584, e.g. a negative potential (-), such that the interrogation signal is transmitted from the blade 582, through the tissue, to the structure 586 of the jaw 584, and returned to the generator via a second different electrical path due to the potential difference between them, so that the generator evaluates the returned signal.
[0095] With respect to the delivery of other energy, e.g., RF energy, to treat tissue, a generator (not shown) is configured to energize the blade 582 to a first potential via a first electrical pathway, e.g., RF energy at a positive potential (+), and energize the structure 586 of the jaws 584 to a second different potential via a second, different electrical pathway, e.g., RF energy at a negative potential (-), to enable conduction of energy, e.g., bipolar RF tissue treatment current, through tissue disposed therebetween to treat the tissue disposed therebetween.
[0096] 9, another end effector assembly 680 is provided in accordance with the present disclosure and configured for use with any of the instruments or systems detailed herein. End effector assembly 680 is similar to end effector assembly 280 (FIGS. 3-5), and thus only the differences therebetween are described in detail below.
[0097] The end effector assembly 680 includes a blade 682 and a jaw 684 including a structure 686, a jaw liner 688, first and second conductive plates 689, and first and second panels 690 disposed on either side of the blade 682. The structure 686 supports the first and second conductive plates 689 on either side of the jaw liner 688. The first and second conductive plates 689 may be electrically insulated from the structure 686 or may be electrically coupled to it (and thus to each other). The first and second conductive plates 689 are configured to connect to a generator to allow for energization of RF energy at a first potential, e.g., a positive potential (+).
[0098] In addition to or as an alternative to providing the above detailed functions of panel 290 (FIGS. 3-5), first and second panels 690 function as electrodes configured to connect to a generator to enable energization of RF energy at a second, different potential, e.g., a negative potential (-). In this manner, RF tissue treatment current can be conducted between plate 689 and panel 690 and through tissue disposed therebetween to treat, e.g., seal, the tissue. Plate 689 and panel 690 can additionally or alternatively be used to probe tissue and sense one or more parameters thereof, in a manner similar to that detailed above.
[0099] 9, for RF tissue treatment or RF tissue probing, the blades 682 may remain unenergized (for RF energy, the blades 682 may be energized with ultrasonic energy to treat tissue with ultrasonic waves). To maintain separation of the blades 682, the sides 683 of the blades 682 and / or the inwardly facing surfaces 691 of the panels 690 may be coated with an insulating coating 699. The insulating coating 699 may be PTFE or other suitable electrically insulating coating.
[0100] As an alternative to blade 682 being unenergized with RF energy, blade 682 may alternatively be energized to the same potential as either panel 690 or plate 689. An insulating coating 699 separates blade 682 from panel 690, while jaw liner 688 separates blade 682 from plate 689, as detailed above.
[0101] 10, yet another end effector assembly 780 is provided in accordance with the present disclosure and configured for use with any of the instruments or systems detailed herein. End effector assembly 780 is similar to end effector assembly 680 (FIG. 9), except that end effector assembly 780 does not include an insulating coating between blade 782 and panel 790. Rather, end effector assembly 780 is configured to maintain a gap distance "G" between blade 782 and each panel 790 at or within a suitable gap distance range to maintain electrical insulation therebetween. Similarly, end effector assembly 780 is configured to maintain a gap distance "GG" similar or different to gap distance "G" between panel 790 and each conductive plate 789 at or within a suitable gap distance range to maintain electrical insulation therebetween. Either or both of gap distances "G", "GG" may be suitable gap distances for sealing tissue, although other gap distances are also contemplated.
[0102] In use, the first and second conductive plates 789 are configured to connect to a generator to enable energization of RF energy at a first potential thereof, e.g., a positive potential (+), while the first and second panels 790 are configured to connect to the generator to enable energization of RF energy at a second, different potential, e.g., a negative potential (-), and function as electrodes such that an RF tissue treatment current may be conducted between the plates 789 and panels 790 and through tissue disposed therebetween, e.g., to treat tissue. The plates 789 and panels 790 may additionally or alternatively be used to probe tissue and sense one or more parameters thereof, in a manner similar to that detailed above.
[0103] For RF tissue treatment or RF tissue probing, the blade 782 may remain unenergized (for RF energy, the blade 782 may be energized with ultrasonic energy to treat tissue with ultrasound). The gap distance "G", "GG" maintains the separation of the blade 782. As an alternative to the blade 782 being unenergized with RF energy, the blade 782 may instead be energized to the same potential as either the panel 790 or the plate 789 with a gap distance "G", "GG" separating the blade 782 therefrom.
[0104] 11A illustrates yet another end effector assembly 880 according to the present disclosure configured for use with any of the instruments or systems detailed herein. End effector assembly 880 is similar to end effector assembly 780 (FIG. 10), except that blade 882 defines a cylindrical configuration and / or a cylindrical rod 890 is provided instead of a panel. In some configurations, an insulating coating is provided between blade 882 and rod 890, similar to that detailed above with respect to end effector assembly 680 (FIG. 9).
[0105] 11B illustrates yet another end effector assembly 980 configured in accordance with the present disclosure and for use with any of the instruments or systems detailed herein. End effector assembly 980 is similar to end effector assembly 780 (FIG. 10), except that a panel 990 defines a shelf 992 extending vertically and outwardly from its vertical body 994. As a result, shelf 992 defines a surface 993 that extends in a generally parallel orientation (e.g., within about 15 degrees) of an opposing surface of structure 986 of jaw 984 in the closed position of jaw 984. In lieu of structure 986 defining an opposing surface, jaw 984 may include a conductive plate in a manner similar to that detailed above.
[0106] In an embodiment, turning to FIG. 12 in conjunction with FIGS. 2-5, the electrical paths connecting the generator to the panel 290 and the generator to the jaws 284 (its structure and / or conductive plates) may be made at least in part by wire leads. Alternatively, structural components may be utilized. For example, the outer tube 210 may define at least a portion of the electrical path connecting the generator to the panel 290, while the inner tube 220 defines at least a portion of the electrical path connecting the generator to the jaws 284. In such a configuration, first and second insulators 212, 222 are provided to electrically insulate the waveguide 230, the inner tube 220, and the outer tube 210 from one another. The insulators 212, 222 may be configured as sheaths, spacing rings, or any other suitable manner to maintain electrical insulation. The waveguide 230, the insulators 212, 222, the inner tube 220, and the outer tube 210 may be concentrically disposed relative to one another.
[0107] 13A, another end effector assembly 1380 is provided in accordance with the present disclosure and configured for use with any of the instruments or systems detailed herein. The end effector assembly 1380 includes a blade 1382 and a jaw 1384 including a structure 1386, a jaw liner 1388, first and second optical elements 1389, and first and second panels 1390 disposed on either side of the blade 1382 and configured as optical elements 1391. The structure 1386 supports the first and second optical elements 1389 on either side of the jaw liner 1388. The first and second optical elements 1389 may be similar or different and may be configured as light emitters, light absorbers, or light reflectors. Similarly, the optical elements 1391 of the panel 1390 may be similar or different, and each pair of opposing optical elements 1389, 1391 may be configured as a light emitter, a light absorber, or a light reflector, such that each pair includes one light emitter and one light absorber or light reflector.
[0108] The optical elements 1389, 1391 configured as light emitters are configured to emit light energy and direct the light energy through tissue disposed between the optical elements 1389, 1391. The optical elements 1389, 1391 configured as light absorbers or light reflectors are configured to absorb the light energy that passes through the tissue or reflect the light energy that passes through the tissue back to the tissue, respectively. This light energy that passes through the tissue may be utilized to treat, e.g., seal, and / or interrogate the tissue. The light energy may include infrared light, ultraviolet light, visible light, laser light, or any other suitable light or combination thereof.
[0109] 13B illustrates another end effector assembly 1480 provided in accordance with the present disclosure and configured for use with any of the instruments or systems detailed herein. The end effector assembly 1480 includes a blade 1482, a jaw 1484 including a structure 1486, a jaw liner 1488 that is transparent to the light wavelengths used (e.g., made from PTFE, among other materials, that is substantially transparent at ultraviolet [UV] wavelengths and corresponding light transmission wavelengths), and first and second optical elements 1489 mounted on or within the structure 1486. The first and second optical elements 1486 are more specifically oriented to emit light energy through the transparent jaw liner 1488 and through tissue disposed between the jaw 1484 and the blade 1482. The blade 1482, in embodiments, may function as a light absorber or reflector and may include coatings or other suitable features to enhance its absorption or reflection.
[0110] The first and second optical elements 1489 may be oriented to direct light energy towards the blade 1482 in a direction generally perpendicular to an outer surface of the blade 1482. More specifically, in some embodiments, the blade 1482 may define a cylindrical configuration with the first and second optical elements 1489 oriented to direct light energy in a direction intersecting the center of the blade 1482, as shown in FIG.
[0111] 14, another end effector assembly 1580 is provided in accordance with the present disclosure and configured for use with any of the instruments or systems detailed herein. The end effector assembly 1580 includes a blade 1582, a jaw 1584 including a structure 1586, a jaw liner 1588, first and second ultrasonic transducers 1589, and first and second panels 1590 disposed on either side of the blade 1582 and configured as ultrasonic absorbers or reflectors 1591. The structure 1586 supports the ultrasonic transducers 1589 on either side of the jaw liner 1588. The first and second ultrasonic transducers 1589 are configured to generate and emit ultrasonic waves toward the panels 1590 and through tissue disposed between the jaw 1584 and the panels 1590, for example, to treat tissue, image tissue, and / or interrogate tissue. The ultrasonic absorbers or reflectors 1591 are configured to absorb or reflect ultrasonic waves that pass through the tissue. Alternatively, this configuration may be reversed on one or both sides, for example, where one or both ultrasonic transducers 1589 are disposed on corresponding panels 1590 and an absorber or reflector 1591 is disposed on the corresponding side of the structure 1586.
[0112] Turning to FIG. 15, yet another end effector assembly 1680 is provided in accordance with the present disclosure and configured for use with any of the instruments or systems detailed herein. The end effector assembly 1680 includes a blade 1682, a jaw 1684 including a structure 1686, a jaw liner 1688, first and second heating elements 1689, and first and second panels 1690 disposed on either side of the blade 1682. The panels 1690 may also include a heating element in some configurations. The first and second heating elements 1689 may include a heating coil configured to generate thermal energy in response to an energy supply of the heating coil. This thermal energy (and thermal energy from the panel 1690, if configured to include a heating element) is transmitted to tissue disposed between the jaw 1684 and the panel 1690, for example, to treat the tissue.
[0113] 16A and 16B show another end effector assembly 1780 that is similar to end effector assembly 280 (FIGS. 3-5), which may include any of its features and / or any of the other end effector assemblies detailed herein. End effector assembly 1780 differs from end effector assembly 280 (FIGS. 3-5) in the configuration of its panels, and therefore only those differences are detailed below.
[0114] The end effector assembly 1780 includes a panel member 1790 having a base 1795 that surrounds a portion of the blade 1782 on the bottom and sides, and first and second panels 1796 extending distally from the base 1795 on either side of the blade 1782.
[0115] The base 1795 defines a U-shaped configuration and extends distally from the outer and / or inner sleeves 1710, 1720 in a fixed or movable relationship. The base 1795, more specifically, extends less than about 50% of the working length of the blade 1782 (defined as the portion of the blade 1782 that opposes the jaw liner 1788 of the jaws 1784 in the closed position), less than about 40% of the working length of the blade 1782, or less than about 30% of the working length of the blade 1782. As a result, the bottom of the blade 1782 is exposed along the distal 50%, 60%, or 70% of its working length.
[0116] A panel 1796 extends distally from a base 1795 on either side of the blade 1782. The panel 1796 may include a shelf 1792 extending vertically and outwardly from an upper end of its vertical body 1794. The panel 1796 may further include a taper from its lower end, such that the height of the panel 1796 gradually tapers from its proximal end toward its distal end. As a result, the bottom and sides of the blade 1782 are increasingly exposed in the proximal to distal direction. This configuration facilitates use of the distal bottom of the blade 1782, for example, for enterotomy, back scoring, and / or other surgical tasks, while providing the functionality of the panel as detailed with respect to any of the configurations above.
[0117] Referring generally to FIGS. 17A-18C (and also applicable to FIGS. 6-16), in contrast to the handle assembly 100 (FIG. 1A) for handheld, manual manipulation and operation, various embodiments disclosed herein may also be configured to cooperate with robotic surgical systems, and what is generally referred to as "teleoperation." Such systems employ various robotic elements to assist the surgeon, allowing remote manipulation (or partial teleoperation) of surgical instrumentation. Various robotic arms, gears, cams, pulleys, electric and mechanical motors, and the like, may be employed for this purpose and designed in the robotic surgical system to assist the surgeon in the course of surgery or treatment. Such robotic systems may include telesteerable systems, automated flexible surgical systems, remote flexible surgical systems, remote articulating surgical systems, wireless surgical systems, modular or selectively configurable teleoperated surgical systems, and the like.
[0118] The robotic surgical system may be used with one or more consoles located adjacent to the operating room or at a remote location. In this case, one team of surgeons or nurses may prepare the patient for surgery, and another surgeon (or group of surgeons) may configure the robotic surgical system with one or more of the instruments disclosed herein while remotely controlling the instruments via the robotic surgical system. As can be appreciated, a highly skilled surgeon may perform multiple operations at multiple locations without leaving his or her remote console, which may be economically advantageous and beneficial to the patient or set of patients.
[0119] The robotic arm of a surgical system is typically coupled to a pair of master handles by a controller. The handles can be moved by the surgeon to generate a corresponding movement of the working end of any type of surgical instrument (e.g., end effector, grasper, knife, scissors, etc.), which may accommodate the use of one or more of the embodiments described herein. The movement of the master handle can be scaled so that the working end has a corresponding movement that is different, smaller, or larger than the movement performed by the surgeon's operating hand. The scale factor or gear ratio can be adjustable to allow the operator to control the resolution of the working end of the surgical instrument.
[0120] The master handle may include various sensors to provide feedback to the surgeon regarding various tissue parameters or conditions, such as tissue resistance to manipulation, cutting, or otherwise manipulating, pressure by the instrument on the tissue, tissue temperature, tissue impedance, etc. As will be appreciated, such sensors provide the surgeon with enhanced tactile feedback that simulates actual operating conditions. The master handle may also include a variety of different actuators for delicate tissue manipulation or treatment that further enhance the surgeon's ability to mimic actual operating conditions.
[0121] 17A-17C, an end effector assembly 1880 is shown for use with a robotic surgical system, although the end effector assembly 1880 may alternatively be used in a handheld instrument and / or any of the other end effector assemblies detailed herein may be used with a robotic surgical system. The end effector assembly 1880 includes a proximal housing 1881c positioned distal to one or more joints 1881a of a robotic shaft assembly 1881b and supporting an ultrasonic transducer 1881d therein or thereon. A waveguide (not explicitly shown) extends distally from the ultrasonic transducer 1881d and includes a blade 1882 defined at its distal end. A jaw 1884 is pivotally mounted to the housing 1881c to permit pivoting of the jaw 1884 relative to the blade 1882 between an open position for clamping tissue between the jaw 1884 and the blade 1882 and a clamping position. The blades 1882 define a cylindrical configuration, although other configurations are contemplated. In some configurations, the jaws 1884 are capable of rotating about the blades 1882.
[0122] The jaw 1884 includes a structure 1886 and a jaw liner 1888. The structure 1886 itself or a conductive plate (not shown) mounted thereon may be configured to connect to a generator to function as one electrode (or portion) of an RF (or other energy-based) circuit. The blade 1882 is configured to connect to a generator to function as the other electrode (or portion) of an RF (or other energy-based) circuit. The opposing surface 1887 of the structure 1886 (or the opposing surface of the conductive plate, if so provided) is rounded to complement the cylindrical configuration of the blade 1882, such that the gap distance between the opposing surface 1887 and the blade 1882 with tissue grasped therebetween is substantially uniform (e.g., within about 15%) at any given time. RF signals may be communicated between the structure 1886 and the blade 1882 to probe and / or treat tissue in a manner similar to that detailed above. Other suitable energy configurations are also contemplated as detailed above.
[0123] 18A-18C, another end effector assembly 1980 for use with a robotic surgical system is shown, although end effector assembly 1880 may alternatively be used with a handheld instrument. End effector assembly 1980 is similar to end effector assembly 1880 (FIGS. 17A-17C) and may include any of the features of end effector assembly 1880 (FIGS. 17A-17C) or any other end effector assembly detailed herein.
[0124] The end effector assembly 1980 is positioned distal to one or more joints 1981a of the robotic shaft assembly 1981b and includes a proximal housing 1981c supporting an ultrasonic transducer 1981d therein. A waveguide (not explicitly shown) extends distally from the ultrasonic transducer 1981d and includes a blade 1982 defined at its distal end. A jaw 1984 is pivotally mounted to the housing 1981c to permit pivoting of the jaw 1984 relative to the blade 1982 between an open position for clamping tissue between the jaw 1984 and the blade 1982 and a clamped position.
[0125] End effector assembly 1980 differs from end effector assembly 1880 (FIGS. 17A-17C) in that end effector assembly 1980 further includes a panel member 1990 having a base 1995 that bottom and side surrounds a portion of blade 1982 and first and second tapered panels 1996 extending distally from base 1995 on either side of blade 1982. Panel member 1990 is similar to and may include any features of panel member 1790 of end effector assembly 1780 (see FIGS. 16A and 16B).
[0126] Although several embodiments of the present disclosure have been described in detail above and shown in the drawings, it is intended that the present disclosure is not limited to these embodiments, as it is believed that the disclosure should be taken as broad as the art permits and that the specification should be read in the same manner. Therefore, the above description and the accompanying drawings should not be interpreted as limiting, but merely as illustrations of certain embodiments. Those skilled in the art will envision other modifications within the scope and spirit of the claims appended hereto.
Claims
1. 1. A surgical end effector assembly, comprising: an ultrasonic blade adapted to connect to an ultrasonic transducer, the ultrasonic transducer configured to transmit ultrasonic energy to the ultrasonic blade; a first panel and a second panel disposed on opposite sides of the ultrasonic blade, the ultrasonic blade being sandwiched between the first panel and the second panel, each of the first panel and the second panel being laterally spaced from the ultrasonic blade to define a gap between the first panel and the second panel, each of the first panel and the second panel, and the ultrasonic blade; a jaw pivotable relative to the ultrasonic blade and the first and second panels between an open and a clamped position; Equipped with At least two of (i) the ultrasonic blade, (ii) the first panel and the second panel, or (iii) the jaws are energizable to a plurality of different electrical potentials for transmitting electrical signals between and through tissue for at least one of probing or treating tissue; A surgical end effector assembly, wherein the ultrasonic blade is configured to be energized to a first electrical potential and the first panel and the second panel are configured to be energized to a second, different electrical potential for transmitting the electrical signals between and through tissue.
2. 2. The surgical end effector assembly of claim 1, wherein the jaws are configured to be energized to a third electrical potential and the first panel and the second panel are configured to be energized to a fourth, different electrical potential for transmitting the electrical signal between and through tissue.
3. 3. The surgical end effector assembly of claim 2, wherein the jaw includes a structure defining a first surface and a second surface and a jaw liner disposed between the first surface and the second surface, the first surface and the second surface being energizable to transmit the electrical signal.
4. 3. The surgical end effector assembly of claim 2, wherein the jaw includes a structure supporting first and second conductive plates and a jaw liner disposed between the first and second conductive plates, the first and second conductive plates being energizable to transmit the electrical signal.
5. The surgical end effector assembly of claim 1, further comprising an insulating coating disposed on at least one of an outer side of the ultrasonic blade or inner sides of the first panel and the second panel.
6. The surgical end effector assembly of claim 1 , wherein a constant gap is maintained between an entire length of an outer side of the ultrasonic blade and an entire length of an inner side of the first panel and the second panel.
7. 2. The surgical end effector assembly of claim 1, wherein each of the first and second panels includes a vertical body and a shelf extending laterally from the vertical body, the shelf defining a facing surface positioned to face the jaw in the clamped position of the jaw.
8. 2. The surgical end effector assembly of claim 1, wherein each of the first and second panels tapers in height in a proximal-to-distal direction from a lower portion thereof to gradually expose a bottom portion of the ultrasonic blade in a proximal-to-distal direction.
9. The surgical end effector assembly of claim 1 , wherein the electrical signal is a radio frequency (RF) signal.
10. The surgical end effector assembly of claim 1 , wherein the electrical signal is a direct current (DC) signal.
Citation Information
Patent Citations
Treatment instrument, treatment device and treatment method
JP2013031669A
Energy treatment instrument
US20120203143A1
Ultrasonic probe and ultrasonic treatment device
US20150196782A1
End effector for instrument with ultrasonic blade and bipolar clamp arm
US20170164973A1
Surgical treatment device
WO2011089769A1
